USD 0.38
(-9.91%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | -215.21 Thousand USD | -199.23% |
2022 | 216.88 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | 100.0% |
2024 Q1 | -139.75 Thousand USD | 35.07% |
2023 Q3 | -54.24 Thousand USD | 3.42% |
2023 Q2 | -56.16 Thousand USD | -109.62% |
2023 FY | -215.21 Thousand USD | -199.23% |
2023 Q1 | 583.96 Thousand USD | 0.0% |
2023 Q4 | -215.21 Thousand USD | -296.74% |
2022 FY | 216.88 Thousand USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AIM ImmunoTech Inc. | -1.18 Million USD | 81.823% |
Ampio Pharmaceuticals, Inc. | 1.00 USD | 21522000.0% |
Armata Pharmaceuticals, Inc. | - USD | Infinity% |
Actinium Pharmaceuticals, Inc. | - USD | Infinity% |
Can-Fite BioPharma Ltd. | - USD | Infinity% |
Chromocell Therapeutics Corporation | - USD | Infinity% |
Calidi Biotherapeutics, Inc. | - USD | Infinity% |
CEL-SCI Corporation | 2.24 Million USD | 109.573% |
iBio, Inc. | - USD | Infinity% |
Lineage Cell Therapeutics, Inc. | - USD | Infinity% |
MAIA Biotechnology, Inc. | - USD | Infinity% |
Matinas BioPharma Holdings, Inc. | - USD | Infinity% |
Navidea Biopharmaceuticals, Inc. | 427.34 Thousand USD | 150.362% |
NovaBay Pharmaceuticals, Inc. | 2.87 Million USD | 107.481% |
NanoViricides, Inc. | - USD | Infinity% |
Oragenics, Inc. | - USD | Infinity% |
BiomX Inc. | - USD | Infinity% |
BiomX Inc. | - USD | Infinity% |
Protalix BioTherapeutics, Inc. | 19.04 Million USD | 101.13% |
Palatin Technologies, Inc. | - USD | Infinity% |
Scorpius Holdings, Inc. | 909.15 Thousand USD | 123.672% |